北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学第一临床医学院  > 消化内科  > 期刊论文
学科主题: 临床医学
题名:
Update on clarithromycin resistance in Helicobacter pylori in Hong Kong and its effect on clarithromycin-based triple therapy
作者: Gu, Q.; Xia, H. H. X.; Wang, J. D.; Wong, W. M.; Chan, A. O. O.; Lai, K. C.; Chan, C. K.; Yuen, M. F.; Fung, F. M. Y.; Wong, K. W.; Lam, Sx.; Wong, B. C. Y.
关键词: Helicobacter pylori ; clarithromycin ; antibiotic resistance ; H. pylori eradication
刊名: DIGESTION
发表日期: 2006
DOI: 10.1159/000094040
卷: 73, 期:2-3, 页:101-106
收录类别: SCI
文章类型: Article
WOS标题词: Science & Technology
类目[WOS]: Gastroenterology & Hepatology
研究领域[WOS]: Gastroenterology & Hepatology
关键词[WOS]: ERADICATION RATES ; ANTIMICROBIAL RESISTANCE ; HIGH PREVALENCE ; DUODENAL-ULCER ; UNITED-STATES ; RABEPRAZOLE ; INFECTION ; METRONIDAZOLE ; OMEPRAZOLE ; AMOXICILLIN
英文摘要:

Aim: To determine the antibiotic susceptibility of Helicobacter pylori and evaluate the efficacy of a clarithromycin-based triple therapy in relation to antibiotic resistance. Methods: Consecutive patients referred for upper endoscopy due to dyspeptic symptoms were recruited. Gastric biopsies were obtained for the CLO test, histology and culture. Antibiotic susceptibility was assessed by the E-test. Patients with H. pylori infection received rabeprazole 20 mg, clarithromycin 500 mg, and anoxicillin 1,000 mg, all twice daily for 7 days. Results: of 234 patients recruited, 124 were H. pylori-positive and culture was successful in 102 patients. The updated prevalences of resistance to clarithromycin, amoxicillin and metronidazole were 7.8, 0 and 39.2%, respectively. A total of 86 patients received 1-week triple therapy with rabeprazole 20 mg, clarithromycin 500 mg, and amoxicillin 1,000 mg, all twice daily, and 81 patients attended the follow-up test. Eradication rates by per-protocol and intention-to-treat analysis were 92.6 and 87.2%, respectively. The eradication rate by per protocol was significantly higher in patients with clarithromycin-susceptible strains than in those with clarithromycin-resistant strains (98.6 vs. 28.6%, p < 0.001). Conclusion: Clarithromycin resistance reduces the clinical efficacy of clarithromycin-based triple therapy. However, due to the low prevalence of clarithromycin resistance, clarithromycin-based therapy is still the first choice for clinical use. Copyright (c) 2006 S. Karger AG, Basel.

语种: 英语
WOS记录号: WOS:000239427800005
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/59035
Appears in Collections:北京大学第一临床医学院_消化内科_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: 1.Univ Hong Kong, Dept Med, Hong Kong, Peoples R China
2.Peking Univ, Hosp 1, Dept Gastroenterol, Beijing 100871, Peoples R China

Recommended Citation:
Gu, Q.,Xia, H. H. X.,Wang, J. D.,et al. Update on clarithromycin resistance in Helicobacter pylori in Hong Kong and its effect on clarithromycin-based triple therapy[J]. DIGESTION,2006,73(2-3):101-106.
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Gu, Q.]'s Articles
[Xia, H. H. X.]'s Articles
[Wang, J. D.]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Gu, Q.]‘s Articles
[Xia, H. H. X.]‘s Articles
[Wang, J. D.]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace